Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 20,000 shares (grant or award)
  2. 4 Grant or award Director acquired 20,000 shares (grant or award)
  3. 4 Open-market buy CEO and President bought 100,000 shares at $10.13 ($1,013,000)
  4. 4 Open-market sale Director sold 34,854 shares at $23.37 ($814,538)
  5. 4 Open-market sale Chief Financial Officer sold 73,647 shares at $26.70 ($1,966,375)
  6. 4 Grant or award Chief Financial Officer acquired 85,000 shares (grant or award)
  7. 4 Grant or award CEO and President acquired 985,000 shares (grant or award)
  8. 4 Open-market buy Director bought 9,000 shares at $10.64 ($95,760)
  9. 4 Open-market sale Director sold 30,000 shares at $11.10 ($333,000)
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
  12. 4 Grant or award Director acquired 43,732 shares (grant or award)
  13. 4 Grant or award Director acquired 43,732 shares (grant or award)
  14. 4 Grant or award Director acquired 43,732 shares (grant or award)
  15. 4 Grant or award Director acquired 43,732 shares (grant or award)
  16. 4 Grant or award Director acquired 43,732 shares (grant or award)
  17. 4 Open-market sale CFO, Secretary and Treasurer sold 84,965 shares at an average $19.10 ($1,622,737)
  18. 4 Open-market sale CEO and President sold 68,220 shares at an average $18.80 ($1,282,527)
  19. 4 Grant or award CFO, Secretary and Treasurer acquired 25,000 shares (grant or award)
  20. 4 Grant or award CEO and President acquired 1,080,770 shares (grant or award)

Page 3 of 18 · 353 filings